News

Private equity firm Carlyle Group is preparing to offload up to a 10% stake in India's Piramal Pharma, online news portal Moneycontrol reported on Thursday, citing sources. The U.S.-based firm could ...
That whole meeting was a travesty,” says Fiona Havers, a physician and epidemiologist. After the ACIP firings, Havers ...
The Vaccine Integrity Project will convene experts to assess the evidence on influenza, RSV, and Covid-19 to equip clinicians ...
People are asking if the Nipah virus is real, after words spread about the zoonotic virus that has an estimated 40-70 percent ...
The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...
Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
The new COVID-flu shot combines the company's updated SARS-CoV-2 vaccine, called mRNA-1283, and its newly developed flu vaccine, mRNA-1010. As of yet, there is no FDA-approved flu shot that ...